These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia. Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696 [TBL] [Abstract][Full Text] [Related]
17. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314 [TBL] [Abstract][Full Text] [Related]
18. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. Wilkoff BL; Hess M; Young J; Abraham WT J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1002-9. PubMed ID: 15363071 [TBL] [Abstract][Full Text] [Related]
19. Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial. Ricci RP; Quesada A; Almendral J; Arribas F; Wolpert C; Adragao P; Zoni-Berisso M; Navarro X; DeSanto T; Grammatico A; Santini M; Europace; 2009 May; 11(5):587-93. PubMed ID: 19401341 [TBL] [Abstract][Full Text] [Related]